Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-7.65 Insider Own25.22% Shs Outstand1.73M Perf Week9.85%
Market Cap1.54M Forward P/E- EPS next Y-3.80 Insider Trans0.00% Shs Float1.29M Perf Month-50.01%
Income-9.34M PEG- EPS next Q-2.40 Inst Own10.88% Short Float1.27% Perf Quarter-57.65%
Sales0.00M P/S- EPS this Y28.29% Inst Trans0.89% Short Ratio0.12 Perf Half Y-62.77%
Book/sh4.19 P/B0.21 EPS next Y25.78% ROA-83.96% Short Interest0.02M Perf Year-85.41%
Cash/sh4.65 P/C0.19 EPS next 5Y- ROE-102.34% 52W Range0.69 - 26.41 Perf YTD-67.64%
Dividend Est.- P/FCF- EPS past 5Y-28.81% ROI-128.55% 52W High-96.63% Beta0.71
Dividend TTM- Quick Ratio4.07 Sales past 5Y0.00% Gross Margin- 52W Low28.96% ATR (14)0.20
Dividend Ex-Date- Current Ratio4.07 EPS Y/Y TTM7.75% Oper. Margin0.00% RSI (14)24.74 Volatility13.17% 17.67%
Employees7 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price11.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-17.35% Payout- Rel Volume0.35 Prev Close0.85
Sales Surprise- EPS Surprise-141.09% Sales Q/Q- EarningsMar 01 BMO Avg Volume139.65K Price0.89
SMA20-37.16% SMA50-49.68% SMA200-72.57% Trades Volume48,235 Change4.61%
Apr-18-24 02:19PM
Apr-16-24 08:00AM
Apr-09-24 10:30AM
Apr-02-24 10:00AM
08:30AM Loading…
Mar-01-24 08:00AM
Jan-22-24 08:30AM
Jan-03-24 08:30AM
Dec-26-23 06:00PM
Nov-15-23 04:05PM
Sep-11-23 08:30AM
Sep-07-23 10:00AM
Sep-05-23 08:30AM
Aug-10-23 04:05PM
06:45AM Loading…
Jul-19-23 09:00AM
Jul-14-23 02:35PM
Jul-12-23 09:05AM
Jul-03-23 09:01AM
Jun-15-23 08:30AM
Jun-07-23 04:30PM
May-18-23 09:00AM
May-15-23 04:45PM
May-02-23 08:30AM
May-01-23 08:30AM
Apr-17-23 09:00AM
Mar-28-23 09:10AM
Mar-16-23 08:00AM
Mar-14-23 08:00AM
04:05PM Loading…
Feb-07-23 04:05PM
Nov-15-22 08:30AM
Nov-08-22 08:30AM
Oct-04-22 09:00AM
Sep-01-22 08:00AM
Aug-16-22 08:05AM
May-17-22 07:00AM
Apr-12-22 09:00AM
Mar-21-22 09:25AM
Mar-17-22 08:00AM
Dec-14-21 08:30AM
Nov-22-21 11:58AM
Nov-16-21 08:00AM
Oct-14-21 08:30AM
Aug-16-21 08:00AM
Jun-15-21 12:46PM
May-24-21 06:35AM
May-13-21 08:15AM
Mar-18-21 09:15AM
Mar-11-21 10:43AM
Mar-08-21 09:00AM
Jan-07-21 08:30AM
Jan-06-21 08:30AM
Jan-04-21 08:30AM
Nov-23-20 08:30AM
Nov-12-20 09:00AM
Nov-05-20 08:30AM
Oct-19-20 09:00AM
Sep-29-20 07:30AM
Sep-09-20 02:15PM
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.